Skip to main content
VRAX logo
VRAX
(NASDAQ)
Virax Biolabs Group Limited
$0.31-- (--)
Loading... - Market loading

Virax Biolabs Group (VRAX) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Virax Biolabs Group Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Virax Biolabs Group Limited income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2020
Period EndingMar 2025Mar 2024Mar 2023Sep 2022Mar 2022Mar 2021Mar 2020
Revenue & Gross Profit
Revenue0.010.160.010.000.000.120.10
Cost of Revenue0.060.110.010.000.000.130.05
Gross Profit-0.050.050.000.000.00-0.010.05
Operating Expenses
Research & Development1.781.562.180.430.430.120.09
Selling, General & Administrative4.334.593.551.301.300.510.61
Operating Expenses6.116.555.731.731.730.640.70
Operating Income-6.16-6.50-5.73-1.73-1.73-0.64-0.65
Other Income/Expense
Interest Income0.000.000.000.020.000.000.00
Interest Expense-0.06-0.030.020.02-0.02-0.030.09
Other Income/Expense-0.040.240.29-0.020.020.03-0.09
Income
Income Before Tax-6.20-6.74-5.46-1.75-1.75-0.67-0.74
Income Tax Expense-0.140.000.000.000.000.000.00
Net Income-6.06-6.73-5.46-1.71-1.71-0.65-0.80
Net Income - Continuous Operations-6.06-6.73-5.46-1.71-1.75-0.65-0.80
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-5.90-6.44-5.440.00-1.73-0.640.00
EBIT-6.16-6.50-5.440.00-1.73-0.640.00
Depreciation & Amortization0.260.050.001.730.000.640.65
Earnings Per Share
Basic EPS-2.00-3.00-5.00-1.00-2.00-4.00-1.00
Diluted EPS-2.00-3.00-5.00-1.00-2.00-4.00-1.00
Basic Shares Outstanding3.732.011.061.140.960.161.14
Diluted Shares Outstanding3.732.011.061.140.960.161.14

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.